Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?

被引:15
|
作者
Rota, S
Flynn, PD
Wareham, NJ
Baglin, TP
Byrne, CD
机构
[1] UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT CLIN BIOCHEM,CAMBRIDGE CB2 1TN,ENGLAND
[2] UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE CB2 1TN,ENGLAND
[3] UNIV CAMBRIDGE,ADDENBROOKES HOSP,INST PUBL HLTH,DEPT COMMUNITY MED,CAMBRIDGE CB2 1TN,ENGLAND
[4] UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT HAEMATOL,CAMBRIDGE CB2 1TN,ENGLAND
基金
英国医学研究理事会;
关键词
platelet phospholipid-dependent thrombin generation; myocardial infarction; aspirin;
D O I
10.1016/0049-3848(96)00141-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ability of unactivated and calcium ionophore activated platelets to support thrombin generation in defibrinated plasma was measured by a chromogenic substrate assay in the absence of clot formation. Platelet phospholipid-dependent thrombin generation (Platelet-TG) could be measured using platelets isolated from blood collected into either sodium citrate or EDTA as anticoagulant. Measurements were stable in samples kept at room temperature for 24 hours after venesection. There was no significant difference in either the unactivated or activated platelet-TG with platelets collected into either anticoagulant (mean difference 10.12 nmol/min unactivated and 10.60 nmol/min activated). There was no correlation between unactivated and activated platelet-TG and patient age. Platelet-TG was 179 (153-237) nmol/min (median and inter-quartile range) for unactivated and 489 (462-508) nmol/min for activated platelets from healthy volunteer subjects (median age 31, range 20-40 years). Platelet-TG was the same in subjects from a population-based cohort study (median age 58, range 45-70 years [162 (142-193) nmol/min and 527 (490-551) nmol/min, unactivated and activated platelets respectively] as compared to patients admitted with acute myocardial infarction (median age 68, range 36-85 years [179 (146-200) nmol/min and 473 (440-517) nmol/min unactivated and activated platelets respectively] (p=0.497 for comparison between unactivated platelet-TGs and p=0.487 for comparison between activated platelet-TGs in the two groups). Aspirin inhibited platelet aggregation but did not affect platelet-TG using either unactivated or activated platelets exposed to aspirin in vitro; or in vivo, using platelets obtained from individuals after ingestion of aspirin. In conclusion these results show that for measurement of platelet -TG, blood samples can be anticoagulated with EDTA as well as sodium citrate for up to 24 hours after venesection and that this measurement is not affected by subject age, aspirin treatment or the acute stage of myocardial infarction.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 50 条
  • [31] Oral aspirin challenge in acute myocardial infarction
    Walia, D. S.
    Stechschulte, D. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S270 - S270
  • [32] Timing of aspirin administration in acute myocardial infarction
    Terry, P
    Davies, M
    EMERGENCY MEDICINE JOURNAL, 2001, 18 (01) : 62 - 63
  • [33] Primary prevention of acute myocardial infarction with aspirin
    Agustí, A
    Diogène, E
    MEDICINA CLINICA, 2004, 122 (15): : 592 - 594
  • [34] UNDERUTILIZATION OF ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
    FISHBEIN, R
    AMERICAN FAMILY PHYSICIAN, 1994, 50 (05) : 898 - &
  • [35] Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation
    Elmas, E
    Kaelsch, T
    Wolpert, C
    Sueselbeck, T
    Bertsch, T
    Dempfle, CE
    Borggrefe, M
    CLINICAL CARDIOLOGY, 2006, 29 (04) : 165 - 169
  • [36] Direct thrombin inhibition with efegatran does not suppress heightened thrombin generation during thrombolysis for acute myocardial infarction
    Miller, JM
    Barsness, GW
    Leimberger, JD
    Gard, J
    Ohman, EM
    Glassman, J
    Brown, DL
    Bengtson, JR
    Marsh, D
    Carr, K
    Moliterno, DJ
    CIRCULATION, 1997, 96 (08) : 2992 - 2992
  • [37] Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction
    Serebruany, VL
    Bahr, RD
    O'Connor, CM
    Lowry, DR
    Gurbel, PA
    CARDIOLOGY, 1998, 90 (01) : 37 - 42
  • [38] Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction
    Pastuszczak, Maciej
    Kotlarz, Agnieszka
    Mostowik, Magdalena
    Zalewski, Jaroslaw
    Zmudka, Krzysztof
    Undas, Anetta
    THROMBOSIS RESEARCH, 2010, 125 (05) : 382 - 386
  • [39] Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction
    Undas, A.
    Pastuszczak, M.
    Kotlarz, A.
    Mostowik, M.
    Zalewski, J.
    Zmudka, K.
    EUROPEAN HEART JOURNAL, 2009, 30 : 931 - 931
  • [40] Reduced thrombin generation is associated with myocardial infarction in the glasgow myocardial infarction study (GLAMIS)
    Smid, M.
    Woodward, M.
    van Oerle, R.
    Spronk, H. M. H.
    Rumley, A.
    ten Cate, H.
    Lowe, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 744 - 745